AIM
IMNM icon

AXA Investment Managers’s Immunome IMNM Stock Holding History

AXA Investment Managers’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.11M Buy
+180,056
New +$1.79M 0.01% 753

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

AXA Investment Managers's IMNM Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Immunome (IMNM) in Q3 2025: 180,056 shares worth $2.11M. The stake represents 0.01% of the portfolio and ranks #753 among its holdings.

153 funds tracked by Wall St. Rank hold IMNM as of Q3 2025.

  • AXA Investment Managers held 180,056 shares of Immunome worth $2.11M as of Q3 2025.
  • Immunome was a new AXA Investment Managers position in Q3 2025.
  • Immunome made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #753 holding.
  • 153 funds tracked by Wall St. Rank held Immunome as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.